The UK has invested in world-class science. The next challenge is investing in the system that enables that science to reach patients.
The translational catalyst programme is a practical response to that challenge.
Instead of creating another funding stream or research initiative, this programme focuses on the relationships, coordination and shared action needed to accelerate translation across the system.
Working with partners from across health research and innovation, the programme will identify common barriers, convene the organisations best placed to address them, and develop practical solutions that can be applied more widely.
This is an investment in the UK's operating system for translation: the relationships, infrastructure and alignment that help research deliver real-world benefit.
Why the Academy of Medical Sciences?
Independent, expert and trusted across the health research and innovation landscape, the Academy is uniquely placed to convene partners around shared challenges and support collective action where no single organisation can act alone.
Our strengths include:
- scientific leadership through a Fellowship spanning the breadth of biomedical research and clinical science
- trusted convening power across academia, industry, healthcare, government and investment
- policy expertise that connects evidence with system change
- independence and neutrality, enabling collaboration around shared national priorities
- a whole-system perspective focused on improving how research becomes real-world benefit.
What the programme will achieve
The translational catalyst programme is designed to strengthen the conditions that enable biomedical innovation to succeed.
The programme will:
- accelerate the journey from discovery to patient benefit
- reduce friction across the translational pathway
- improve coordination across researchers, regulators, funders, the NHS and industry
- develop scalable approaches that can be applied across technologies and disease areas
- increase confidence in the UK as a place to develop, test, adopt and scale biomedical innovation
- unlock greater value from public and private research investment.
Success will not be measured by a single project, but by a stronger system that enables many more discoveries to reach patients.
A partnership opportunity
Founding partners will help build the UK's long-term capability for medical translation by strengthening the relationships, infrastructure and coordination that enable discovery to become patient benefit.
They will help shape programme priorities, contribute strategic insight and work alongside leaders from across the ecosystem to create lasting improvements to the UK's translational infrastructure.
Partnership offers the opportunity to:
- influence programme priorities and governance
- contribute expertise to nationally significant challenges
- build relationships across academia, healthcare, government and industry
- gain early insight into emerging developments and system thinking
- demonstrate leadership in supporting a stronger UK life sciences environment.
For partners, a stronger translational system means clearer pathways, less friction and greater confidence in the journey from discovery to adoption.
For patients and society, it means earlier access to life-changing advances and greater value from research investment.
For the UK, it strengthens long-term capability and global competitiveness in life sciences.
Join us
The UK has the science, the talent and the ambition to lead globally in biomedical innovation. The next step is to ensure the system works as effectively as the science itself.
Our translational catalyst programme is designed to help achieve that, and together we can make that happen.
Become a founding partner and help build the conditions that allow world-class science into patient benefit, faster.